Jay Moyes
Board Member
Sintx Technologies, Inc. (SINT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sintx Technologies, Inc. publishes a filing, an earnings call transcript or a press release.
Get SINT alertsAbout Jay Moyes
Jay Moyes is recorded as Board Member at Sintx Technologies, Inc. (SINT). The newest filing on record that lists Jay Moyes as Board Member at Sintx Technologies, Inc. (SINT) is dated October 30, 2026. Jay Moyes was last confirmed as Board Member at Achieve Life Sciences, Inc. (ACHV) in a filing dated April 21, 2022. Earlier roles on record: CFO at Sera Prognostics, Inc. (SERA) until June 7, 2023. Sera Prognostics, Inc. reported in an 8-K filed May 25, 2023 that Jay Moyes resigned as Treasurer and Chief Financial Officer, effective June 7, 2023. The proxy statement of Sera Prognostics, Inc. reports total compensation of $945,539 for Jay Moyes in fiscal 2022, including a base salary of $421,100. Disclosed compensation is on record for 2 fiscal years. Jay Moyes has spoken on 6 earnings calls across 1 company, most recently for Sera Prognostics, Inc. on May 10, 2023. Sintx Technologies, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls Jay Moyes spoke on are classified in the Healthcare sector. Other leadership on record at Sintx Technologies, Inc. includes Eric K. Olson (CEO, Chairman and Board Member), Eric Olson (CEO), B. Sonny Bal (Chairman) and 7 others.
“On May 22, 2023, Jay Moyes notified Sera Prognostics, Inc. (the “Company”) of his intention to resign from the position of Treasurer and Chief Financial Officer of the Company, effective as of June 7, 2023.”
Jay Moyes on recent calls
“Let me review at a high level our financial results for the first quarter and our general view for 2023. Revenue for the first quarter of 2023 was $100,000 compared to $38,000 for the first quarter of 2022.”
“Let me briefly review our financial results for the fourth quarter, and then I'll provide some color on what our views are for 2023. Revenue for the fourth quarter of 2022 was $65,000 compared to $26,000 for the fourth quarter of 2021.”
“Today, I'll briefly review our financial results for the third quarter and provide some general commentary for our view through year-end. For the third quarter of 2022, we reported revenue of $87,000 compared to $23,000 for the third quarter of 2021.”
“Today, I'll briefly review our financial results for the second quarter and provide some general color on cost reduction efforts we've undertaken and our high-level view on testing revenue for the rest of the year.”
“Today, I’ll briefly review our financial results for the first quarter and then provide some general commentary on our outlook. For the first quarter of 2022, we reported revenue of $38,000 compared to $13,000 for the same period of 2021.”
Affiliation history
-
Current
Start not stated–present
Last confirmed October 30, 2026
-
2017-01-01–2022-04-21
Last confirmed by a filing; no departure on record
-
Start not stated–2023-06-07
Company network
Biotechnology · Healthcare
Board Member
Since 2017-01-01, last confirmed 2022-04-21
Leadership on record at Sintx Technologies, Inc.
- Eric K. Olson CEO, Chairman, Board Member
- Eric Olson CEO
- B. Sonny Bal Chairman
- Kevin Trask CFO
- David O’Brien COO
- Chris Lyons Board Member
- Gregg Honigblum Board Member
- Jay M. Moyes Board Member
- Mark Anderson Board Member
- Robert D. Mitchell Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Sera Prognostics, Inc. (SERA) | Chief Financial Officer Represents the aggregate grant date fair value of option awards granted in the applicable fiscal year. Grant date fair value is calculated in accordance with Accounting Standards Codification (“ASC”) Topic 718 (“ASC 718”) issued by the Financial Accounting Standards Board. For the assumptions relating to valuations of equity awards made to our named executive officers, see Note 11 to our audited financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 22, 2023. Consists of bonus payments received under our non-equity incentive compensation plans based upon satisfaction of performance goals. See “Executive Compensation — Non-Equity Incentive Compensation Plan.” Consists of matching contributions made under our 401(k) plan on behalf of each NEO. Dr. Foley’s employment commenced on December 30, 2021, and his compensation in 2021 consisted of a sign-on bonus. | $421,100 | $945,539 |
| 2021 | Sera Prognostics, Inc. (SERA) | Chief Financial Officer Represents the aggregate grant date fair value of option awards granted in the applicable fiscal year. Grant date fair value is calculated in accordance with Accounting Standards Codification (“ASC”) Topic 718 (“ASC 718”) issued by the Financial Accounting Standards Board. For the assumptions relating to valuations of equity awards made to our named executive officers, see Note 11 to our audited financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 22, 2023. Consists of bonus payments received under our non-equity incentive compensation plans based upon satisfaction of performance goals. See “Executive Compensation — Non-Equity Incentive Compensation Plan.” Consists of matching contributions made under our 401(k) plan on behalf of each NEO. Dr. Foley’s employment commenced on December 30, 2021, and his compensation in 2021 consisted of a sign-on bonus. | $380,100 | $945,891 |